TopFunds

Albemarle Corporation

NYSE: ALB

Stock price

90.82 USD

(+0%) TODAY

Specialty ChemicalsChemicals - Specialty
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
3
5.7
0.5
6.3
5
3.5
1.1
22.8
13.4
(11.2)
(5.7)
-
02Free cash flow per share
1.2
4.7
(0.1)
(1.4)
(1.2)
(0.5)
(5.2)
5.5
(7)
(8.4)
5.9
17.3%
03Dividends per share
1.2
1.2
1.3
1.3
1.5
1.5
1.6
1.6
1.6
1.6
1.6
3.4%
04Dividends payout, %
35.6%
21%
2.6%
20.9%
28.5%
43.1%
1.4%
6.9%
11.9%
(26.4)%
(70)%
-
PROFIT AND LOSS STATEMENT
05Revenue
$ 2,826
$ 2,677
$ 3,072
$ 3,375
$ 3,589
$ 3,129
$ 3,328
$ 7,320
$ 9,617
$ 5,378
$ 5,143
6.2%
06% Change
-
(5.3)%
14.8%
9.9%
6.4%
(12.8)%
6.4%
120%
31.4%
(44.1)%
(4.4)%
6.2%
07Cost of revenue
(1,966)
(1,707)
(1,949)
(2,154)
(2,331)
(2,133)
(2,320)
(4,235)
(8,416)
(5,317)
(4,471)
8.6%
08Gross profit
860.2
970.6
1,124
1,221
1,259
995.6
1,009
3,086
1,201
60.2
671.6
(2.4)%
09% Margin
30.4%
36.3%
36.6%
36.2%
35.1%
31.8%
30.3%
42.2%
12.5%
1.1%
13.1%
27.8% A
10Operating expenses
(389.6)
(460.9)
(500.9)
(496.7)
(573.5)
(469.8)
(475.8)
(584.1)
(959.9)
(696.2)
(577.8)
4%
11% of Revenue
(13.8)%
(17.2)%
(16.3)%
(14.7)%
(16)%
(15)%
(14.3)%
(8)%
(10)%
(13)%
(11.2)%
(13.6)% A
12Operating Income
470.6
509.6
622.6
724.3
685.3
525.7
532.7
2,502
241.1
(636)
93.8
(14.9)%
13Income tax expense
(11.1)
(96.3)
(431.8)
(144.8)
(88.2)
(54.4)
(29.4)
(390.6)
(430.3)
(87.1)
(156.9)
30.3%
14Net Income
334.9
643.7
54.9
693.6
533.2
375.8
123.7
2,690
1,574
(1,179)
(510.6)
-
15% Margin
11.9%
24%
1.8%
20.6%
14.9%
12%
3.7%
36.8%
16.4%
(21.9)%
(9.9)%
10% A
16Shares Outstanding
111,556
113,239
112,380
109,458
106,321
106,808
116,536
117,793
117,766
117,516
117,701
0.5%
17EPS Basic
3
5.7
0.5
6.4
5
3.5
1.1
23
13.4
(11.2)
(5.7)
-
18EPS Diluted
3
5.7
0.5
6.3
5
3.5
1.1
22.8
13.4
(11.2)
(5.7)
-
19EBITDA
730.7
735.8
819.5
925
898.8
757.7
544.9
3,630
2,647
(294.1)
558
(2.7)%
% Margin
25.9%
27.5%
26.7%
27.4%
25%
24.2%
16.4%
49.6%
27.5%
(5.5)%
10.9%
23.2% A
20Net Interest Income (expense)
(81.6)
(65.2)
(115.3)
(52.4)
(57.7)
(73.1)
(61.5)
(123)
(116.1)
(165.6)
(207.7)
9.8%
21Net Debt / EBITDA
4.9
0.1
0.9
1.2
2.9
3.9
3.8
0.5
1.3
(8.2)
3
1.3 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
213.7
2,270
1,137
555.3
613.1
746.7
439.3
1,499
889.9
1,192
1,618
22.4%
23Short-term investments
-
-
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
495.6
543.1
619.4
697.9
752.4
530.8
700.1
1,449
1,835
1,066
764.8
4.4%
25Other current assets
682.2
43.5
128.1
44.7
90.6
178.4
55.7
163.2
330.5
81.9
446.1
(4.2)%
26Inventory
508.7
450.3
592.8
700.5
769
750.2
798.6
2,076
2,161
1,503
1,179
8.8%
27Total Current Assets
1,831
3,307
2,478
1,998
2,225
2,206
1,994
5,187
5,217
3,842
4,008
8.2%
Non-Current Assets
28Net property, plant & equipment
2,485
2,360
2,493
3,021
5,043
5,355
6,064
7,091
9,633
9,450
8,729
13.4%
29Long-term investments
455.4
457.5
534.1
528.7
579.8
656.2
912
1,151
1,370
1,118
900.9
7.1%
30Other non-current assets
4,844
2,037
2,246
2,033
2,013
2,234
2,004
2,028
2,051
2,199
2,736
(5.6)%
31Total Non-Current Assets
7,784
4,855
5,273
5,583
7,636
8,245
8,980
10,270
13,054
12,767
12,366
4.7%
Total Assets
9,615
8,161
7,751
7,582
9,861
10,451
10,974
15,457
18,271
16,610
16,374
5.5%
LIABILITIES
Current Liabilities
32Accounts payable
239.6
281.9
418.5
522.5
574.1
483.2
648
2,052
2,088
943.9
913.5
14.3%
33Short-term debt
675
247.5
422
307.3
210.5
804.7
389.9
2.1
625.8
398
74.1
(19.8)%
34Other current liabilities
702.1
610.7
360.4
353.4
624.4
514
836.4
686.9
846.7
624.6
810.4
1.5%
35Total Current Liabilities
1,617
1,140
1,201
1,183
1,409
1,802
1,874
2,741
3,561
1,967
1,798
1.1%
Non-Current Liabilities
36Long-term debt
3,142
2,122
1,415
1,398
2,978
2,884
2,131
3,314
3,655
3,218
3,223
0.3%
37Other non-current liabilities
1,455
956.8
1,317
1,242
1,381
1,296
1,163
1,210
1,390
1,226
1,572
0.8%
38Total Non-Current Liabilities
4,597
3,079
2,732
2,639
4,358
4,181
3,294
4,525
5,045
4,444
4,795
0.4%
39Total Liabilities
6,214
4,219
3,933
3,823
5,767
5,982
5,169
7,266
8,606
6,410
6,593
0.6%
SHAREHOLDERS` EQUITY
40Common stock
1.1
1.1
1.1
1.1
1.1
1.1
1.2
1.2
1.2
1.2
1.2
0.5%
41Retained earnings / (deficit)
1,615
2,122
2,035
2,566
2,944
3,155
3,097
5,601
6,987
5,482
4,614
11.1%
42Accumulated other comprehensive income / (loss)
(421.3)
(412.4)
(225.7)
(350.7)
(395.7)
(326.1)
(392.4)
(560.7)
(528.5)
(742.1)
(334.8)
(2.3)%
43Noncontrolling interests
146.9
147.5
143.1
173.8
161.3
200.4
180.3
208.2
252.9
238.2
248.1
5.4%
44Total shareholders' equity
3,401
3,943
3,818
3,759
4,094
4,469
5,806
8,191
9,665
10,200
9,782
11.1%
45Total Liabilities and shareholders' Equity
9,615
8,161
7,751
7,582
9,861
10,451
10,974
15,457
18,271
16,610
16,374
5.5%
46Total Debt
3,817
2,369
1,837
1,705
3,188
3,689
2,521
3,316
4,280
3,616
3,297
(1.5)%
47Net Debt
3,603
99.5
700.1
1,150
2,575
2,942
2,082
1,817
3,391
2,423
1,679
(7.4)%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
334.9
643.7
54.9
693.6
533.2
375.8
123.7
2,690
1,574
(1,179)
(510.6)
-
49Depreciation & amortization
260.1
226.2
196.9
200.7
213.5
232
254
300.8
429.9
588.6
658.7
9.7%
50Share-based compensation expense
15.2
17
19.4
15.2
19.7
22.8
20.1
30.5
36.5
32.1
40.3
10.2%
51Changes in working capital and other assets
(249.5)
(153.5)
32.8
(363.3)
(47)
168.3
(53.5)
(1,113)
(713.4)
1,247
1,094
-
52Net cash flows from operating activities
360.7
733.4
304
546.2
719.4
798.9
344.3
1,908
1,327
687.9
1,282
13.5%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(227.6)
(196.7)
(317.7)
(700)
(851.8)
(850.5)
(953.7)
(1,262)
(2,155)
(1,681)
(589.8)
10%
54Purchases of investments / marketable securities
-
-
(0.3)
(5.9)
(2.6)
(2.4)
(6.5)
(0.7)
(204.5)
(15.6)
-
-
55Proceeds from maturities of marketable securities
1
0.3
-
-
0.4
0.9
3.8
1.9
221.8
82.5
411.2
82.6%
56Other investing activities
(1,934)
3,117
(39.8)
402.2
(809.6)
(11.6)
289.8
(162.2)
(427.4)
28.8
32.6
-
57Net cash flows from investing activities
(2,161)
2,921
(357.8)
(303.7)
(1,664)
(863.6)
(666.6)
(1,423)
(2,565)
(1,585)
(146)
(23.6)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
-
-
(250)
(500)
-
-
1,454
-
-
-
-
-
59Dividends paid, net
(119.3)
(135.4)
(140.6)
(144.6)
(152.2)
(161.8)
(177.9)
(184.4)
(187.2)
(311.3)
(357.3)
11.6%
60Debt issuance (repayments), net
(278.3)
(1,416)
(612.5)
(113.6)
1,296
339.8
(1,113)
867.6
944.2
(631.8)
(454.7)
5%
61Other financing activities
(80.7)
(26.5)
(83.9)
(28.4)
(101.3)
(0.7)
(113)
(71.2)
(133.1)
2,185
(22.2)
(12.1)%
62Net cash flows from financing activities
(478.3)
(1,578)
(1,087)
(786.5)
1,043
177.3
50.2
611.9
623.9
1,242
(834.2)
5.7%
63Increase (decrease) in cash and cash equivalents
(2,276)
2,056
(1,133)
(582)
57.8
133.6
(307.5)
1,060
(609.2)
302.3
425.8
-
64Cash and equivalents, ending balance
213.7
2,270
1,137
555.3
613.1
746.7
439.3
1,499
889.9
1,192
1,618
22.4%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
133
536.7
(13.7)
(153.8)
(132.4)
(51.6)
(609.4)
646.2
(828)
(992.7)
692.5
17.9%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Albemarle Corporation (ALB) financial statements and performance

Explore Albemarle Corporation (ALB) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.